Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 28.62%6.32B | 25.29%4.91B | 6.28%3.92B | 39.08%3.69B | 36.80%2.65B | 42.70%1.94B | 40.60%1.36B | 10.07%966.77M | -2.16%878.3M | 5.98%897.7M |
| Revenue from customers | 28.45%6.32B | 20.64%4.92B | 10.41%4.08B | 35.55%3.7B | 40.54%2.73B | 42.70%1.94B | 40.60%1.36B | 10.07%966.77M | -2.16%878.3M | 5.98%897.7M |
| Other cash income from operating activities | 82.89%-1.3M | 95.18%-7.6M | -3,326.09%-157.6M | 93.66%-4.6M | ---72.6M | ---- | ---- | ---- | ---- | ---- |
| Cash paid | -15.21%-3.21B | -7.44%-2.79B | -19.34%-2.59B | -52.91%-2.17B | -20.18%-1.42B | -32.46%-1.18B | -71.57%-892.98M | -15.10%-520.49M | 10.65%-452.2M | -12.54%-506.09M |
| Payments to suppliers for goods and services | -15.21%-3.21B | -7.44%-2.79B | -19.34%-2.59B | -52.91%-2.17B | -20.18%-1.42B | -32.46%-1.18B | -71.57%-892.98M | -15.10%-520.49M | 10.65%-452.2M | -12.54%-506.09M |
| Direct interest paid | -17.00%-86.7M | -216.67%-74.1M | -157.14%-23.4M | 45.83%-9.1M | -79.54%-16.8M | -463.67%-9.36M | -214.99%-1.66M | -65.20%-527K | 74.64%-319K | 34.38%-1.26M |
| Direct interest received | 12.36%60M | 104.60%53.4M | 392.45%26.1M | 96.30%5.3M | -36.68%2.7M | -13.63%4.26M | -33.42%4.94M | 22.54%7.42M | 57.17%6.05M | 85.19%3.85M |
| Direct tax refund paid | -261.73%-129.5M | -271.29%-35.8M | -75.81%20.9M | 161.32%86.4M | -241.30%-140.9M | 54.31%-41.28M | 9.75%-90.35M | -36.95%-100.11M | -572.31%-73.1M | 71.80%-10.87M |
| Operating cash flow | 42.65%2.95B | 53.19%2.07B | -15.49%1.35B | 48.51%1.6B | 51.57%1.08B | 87.35%710.44M | 7.40%379.2M | -1.58%353.06M | -6.42%358.73M | 6.78%383.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1.95%-1.53B | -43.99%-1.5B | -18.30%-1.04B | -242.78%-881.3M | 84.61%-257.1M | -157.71%-1.67B | -162.09%-648.14M | -20.99%-247.29M | -7.73%-204.39M | 20.77%-189.72M |
| Capital expenditure reported | -86.11%-254.6M | 1.65%-136.8M | -15.24%-139.1M | 17.04%-120.7M | -90.38%-145.5M | 12.32%-76.43M | -92.11%-87.17M | 19.58%-45.37M | 8.31%-56.42M | -72.77%-61.54M |
| Net PPE purchase and sale | -55.82%-2.03B | -41.64%-1.3B | -1.33%-920.1M | -67.13%-908M | -93.07%-543.3M | -41.67%-281.4M | -32.09%-198.64M | 14.04%-150.38M | -36.65%-174.95M | -13.70%-128.03M |
| Net intangibles purchas and sale | 958.31%547.6M | -1,038.24%-63.8M | --6.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net business purchase and sale | 0.00%5M | 0.00%5M | -98.35%5M | -24.50%303.9M | 130.59%402.5M | -273.46%-1.32B | -1,583.28%-352.28M | -215.69%-20.93M | --18.09M | ---- |
| Net investment purchase and sale | 8,525.00%202.2M | -150.00%-2.4M | 103.03%4.8M | -620.72%-158.3M | 1,256.77%30.4M | 86.93%-2.63M | 34.30%-20.11M | -487.65%-30.61M | 5,295.39%7.9M | 69.60%-152K |
| Net other investing changes | ---- | ---- | 277.78%6.8M | 250.00%1.8M | -120.87%-1.2M | --5.75M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1.95%-1.53B | -43.99%-1.5B | -18.30%-1.04B | -242.78%-881.3M | 84.61%-257.1M | -157.71%-1.67B | -162.09%-648.14M | -20.99%-247.29M | -7.73%-204.39M | 20.77%-189.72M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -67.17%-965.6M | -335.08%-577.6M | 126.49%245.7M | -29.06%-927.4M | -151.89%-718.6M | 1,445.56%1.38B | 236.10%89.6M | 1.19%-65.83M | -45.74%-66.62M | -32.52%-45.71M |
| Net issuance payments of debt | ---- | -101.22%-9.5M | 239.23%781.8M | -72.77%-561.5M | -146.86%-325M | --693.6M | ---- | ---- | ---- | ---- |
| Net common stock issuance | -267.78%-176.9M | 63.75%-48.1M | -584.02%-132.7M | -781.82%-19.4M | -100.27%-2.2M | 352.73%803.13M | 3,734.74%177.4M | 115.06%4.63M | --2.15M | ---- |
| Cash dividends paid | -67.49%-558.9M | -30.71%-333.7M | -16.95%-255.3M | 29.69%-218.3M | -537.97%-310.5M | 30.81%-48.67M | -11.06%-70.34M | -5.47%-63.33M | -66.74%-60.05M | -35.75%-36.01M |
| Net other financing activities | 39.30%-229.8M | -27.82%-378.6M | -15.52%-296.2M | -58.47%-256.4M | -27.84%-161.8M | -262.47%-126.56M | -145.09%-34.92M | 18.35%-14.25M | 10.06%-17.45M | -21.77%-19.4M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -67.17%-965.6M | -335.08%-577.6M | 126.49%245.7M | -29.06%-927.4M | -151.89%-718.6M | 1,445.56%1.38B | 236.10%89.6M | 1.19%-65.83M | -45.74%-66.62M | -32.52%-45.71M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.21%1.12B | 98.44%1.13B | -26.01%571.1M | 13.97%771.9M | 154.45%677.3M | -39.91%266.18M | 9.91%443M | 27.82%403.06M | 88.33%315.34M | 103.24%167.44M |
| Current changes in cash | 5,545.24%457.4M | -101.51%-8.4M | 364.73%554.6M | -307.22%-209.5M | -76.21%101.1M | 336.92%424.9M | -549.06%-179.34M | -54.47%39.94M | -40.69%87.72M | 73.88%147.9M |
| Effect of exchange rate changes | 252.83%8.1M | -169.74%-5.3M | -12.64%7.6M | 363.64%8.7M | 76.12%-3.3M | -647.58%-13.82M | --2.52M | ---- | ---- | ---- |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---3.2M | ---- | ---- | ---- | ---- | ---- |
| End cash Position | 41.58%1.59B | -1.21%1.12B | 98.44%1.13B | -26.01%571.1M | 13.97%771.9M | 154.44%677.26M | -39.91%266.18M | 9.91%443M | 27.82%403.06M | 88.33%315.34M |
| Free cash from | 16.10%657M | 94.94%565.9M | -49.11%290.3M | 48.68%570.5M | 10.33%383.7M | 276.55%347.76M | -41.14%92.36M | 23.72%156.89M | -34.53%126.81M | -7.47%193.7M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |